Clorox Co /De/ financial data

Symbol
CLX on NYSE
Location
The Clorox Company, 1221 Broadway, Oakland, CA
Fiscal year end
June 30
Latest financial report
10-K - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 86.8 % -4.9%
Quick Ratio 31.8 % -9%
Debt-to-equity 5.76K % +12%
Return On Equity 319 % +212%
Return On Assets 14.6 % +206%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122M shares -1.25%
Common Stock, Shares, Outstanding 123M shares -1.21%
Entity Public Float 19.9B USD +12.4%
Common Stock, Value, Issued 131M USD 0%
Weighted Average Number of Shares Outstanding, Basic 124M shares -0.52%
Weighted Average Number of Shares Outstanding, Diluted 124M shares -0.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.1B USD +0.16%
Research and Development Expense 121M USD -3.97%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.08B USD +171%
Income Tax Expense (Benefit) 254M USD +140%
Net Income (Loss) Attributable to Parent 810M USD +189%
Earnings Per Share, Basic 6 USD/shares +190%
Earnings Per Share, Diluted 6 USD/shares +190%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 167M USD -17.3%
Inventory, Net 523M USD -17.9%
Assets, Current 1.61B USD -0.86%
Property, Plant and Equipment, Net 1.27B USD -3.65%
Operating Lease, Right-of-Use Asset 333M USD -7.5%
Intangible Assets, Net (Excluding Goodwill) 566M USD -16.9%
Goodwill 1.23B USD +0.08%
Other Assets, Noncurrent 558M USD +2.39%
Assets 5.56B USD -3.3%
Accounts Payable, Current 838M USD -11.8%
Employee-related Liabilities, Current 179M USD -5.79%
Liabilities, Current 1.92B USD +21.9%
Deferred Income Tax Liabilities, Net 20M USD -9.09%
Operating Lease, Liability, Noncurrent 305M USD -8.68%
Other Liabilities, Noncurrent 351M USD -58.6%
Liabilities 5.08B USD -3.42%
Accumulated Other Comprehensive Income (Loss), Net of Tax -157M USD -1.29%
Retained Earnings (Accumulated Deficit) 432M USD +72.8%
Stockholders' Equity Attributable to Parent 321M USD -2.13%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 482M USD -2.03%
Liabilities and Equity 5.56B USD -3.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 221M USD +1005%
Net Cash Provided by (Used in) Financing Activities -237M USD -253%
Net Cash Provided by (Used in) Investing Activities 89M USD
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 131M shares 0%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 75M USD -50.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 170M USD -17.9%
Deferred Tax Assets, Valuation Allowance 166M USD +44.3%
Deferred Tax Assets, Gross 560M USD +9.59%
Operating Lease, Liability 392M USD -6.22%
Payments to Acquire Property, Plant, and Equipment 39M USD +62.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 808M USD +30.7%
Lessee, Operating Lease, Liability, to be Paid 432M USD -6.29%
Property, Plant and Equipment, Gross 4.18B USD +1.02%
Operating Lease, Liability, Current 87M USD +3.57%
Lessee, Operating Lease, Liability, to be Paid, Year Two 94M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 101M USD +4.12%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +27.8%
Deferred Income Tax Expense (Benefit) -1M USD +80%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 40M USD -6.98%
Lessee, Operating Lease, Liability, to be Paid, Year Three 82M USD -2.38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 27M USD +22.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 68M USD -1.45%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7M USD -12.5%
Depreciation, Depletion and Amortization 54M USD -11.5%
Deferred Tax Assets, Net of Valuation Allowance 394M USD -0.51%
Interest Expense 88M USD -2.22%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%